FDA Approved: EPIOXA CROSS-LINKING — Original Application (Glaukos Corporation)

View source ↗

Summary

The FDA approved the original application for EPIOXA CROSS-LINKING (riboflavin 5-phosphate ophthalmic) by Glaukos Corporation for use in corneal cross-linking t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Drugs mentioned

• EPIOXA CROSS-LINKING (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC)

Snippet

ORIG AP for EPIOXA CROSS-LINKING (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC)